当前位置: X-MOL 学术Nat. Biotechnol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Editor’s pick: Tenpoint Therapeutics
Nature Biotechnology ( IF 33.1 ) Pub Date : 2024-06-19 , DOI: 10.1038/s41587-024-02281-5
Charles Schmidt

Each year, Nature Biotechnology highlights companies that have received sizeable early-stage funding in the previous year. Tenpoint Therapeutics optimizes delivery and generation of stem-cell-derived retinal cells for vision repair.

中文翻译:


编辑推荐:Tenpoint Therapeutics



每年,《自然生物技术》都会重点介绍在上一年获得大量早期融资的公司。 Tenpoint Therapeutics 优化用于视力修复的干细胞衍生视网膜细胞的输送和生成。
更新日期:2024-06-19
down
wechat
bug